REFERENCES
- Hunter J. A. A., Finlay B. Scanning electron microscopy of connective tissues in health and disease. Int. Rev. Connective Tissue Res. 1973; 6: 217–255
- Mackenzie I. C. An examination of cellular organization withinthe stratum corneum by a silver staining method. J. Invest. Dermatol. 1973; 61: 245–250
- McGinley K. J., Marples R. R., Plemig G. A method for visualizing and quantitating portion of the stratum corneum. J, Invest. Dermatol. 1969; 53: 107–111
- Mackenzie I. C. Ordered structure of the stratum corneum of mammalian skin, Nature. 1969; 222: 881–882
- Christophers E. Cellular architecture of the stratum corneum of mammalian skin. J. Invest. Dermatol. 1971; 56: 165–169
- Scheuplein R. J. Properties of the skin. Adv. Biol. Skin 1972; 12: 125–152
- Michael A. S., Chandrasekaran S. K., Shaw J. E. Drug permeation through human skin: theory and in vitro experimental measurement. AIChE J. 1975; 21(5)985–996
- Chandrasekeran S. K., Shaw J. E. Factors influencing the percutaneous absorption of drugs. Curr. Probl. Dermatol. 1978; 7: 142–155
- Elias P. M. Epidermal lipids, barrier function, and desquamation. J. Invest. Dermatol. 1983; 80: 44s–49s
- Tojo K. Random brick model for drug transport across stratum corneum. J. Pharm. Sci. 1987; 76(12)889–891
- Potts R. O., Guy R. H. Mechanism of Transdermal Drug Delivery. Marcel Dekker, New York 1997; 1–40
- Lampe M. A., Williams M. L., Elias P. M. Human epidermal lipids: characterization and modulations during differentiation. J. Lipid Res. 1983; 24: 131–140
- Kuo P. C., Liu J. C., Chang S. F., Chien S. F. In vitro transdermal permeation of oxycodone: (I) effect of pH, delipidization and skin stripping. Drug Dev. Ind. Pharm. 1989; 15(8)1199–1215
- Harada K., Murakami T., Yata N., Yamamoto S. Role of intercellular lipids in stratum corneum in the percutaneous permeation of drugs. J. Invest Dermatol. 1992; 99(3)278–282
- Raykar P. V., Fung M. C., Anderson B. D. The role of protein and lipid domains in the uptake of solubility by human stratum corneum. Pharm. Res. 1988; 5(3)140–150
- Aspe E., Guy R. H., Lee W. A., Kennedy J. A., Visor G. C., Enniss R. D. Optimization of in vitro flux through hairless mouse skin of cidofovir, a potent nucleotide analog. J. Pharm. Sci. 1995; 84(6)750–754
- Higo N., Hinz R. S., Lau D. T. W., Benet L. Z., Guy R. H. Cutaneous metabolism of nitroglycerin in vitro. II. Effects of skin condition and penetration enhancement. Pharm. Res. 1992; 9(3)303–306
- Shah H. S., Tojo K., Chien Y. W. Transdermal controlled delivery of verapamil: characterization of in vitro skin permeation. Int. J. Pharm. 1992; 86: 167–173
- Werts P. W., Downing D. Covalent attachment of ω-hydroxyacid derivatives to epidermal macromolecules: a preliminary characterization. Biochem. Biophys. Res. Commun. 1986; 137(3)992–997
- Knutson K., Krill S. L., Lambert W. J., Higuchi W. I. Controlled Release Technology: Pharmaceutical Applications, P. I. Lee, W. R. Good. ACS Symposium Series 348, Washington, D.C. 1987; 241–266
- Tsai J. C., Weiner N., Flynn G. L., Ferry J. J. Drug and vehicle deposition from topical applications of minoxidil with skin strata of the hairless mouse. Skin Pharmacol. 1994; 7(5)262–269
- Flynn G. L., Durrheim H., Higuchi W. I. Permeation of hairless mouse skin II: membrane sectioning techniques and influence on alkanol permeabilites. J. Pharm. Sci. 1981; 70(1)52–56
- Cooper E. R. Increased skin permeability for lipophilic molecules. J. Pharm. Sci. 1984; 73(8)1153–1156
- Elias P. M., Friend P. S. The permeability barrier in mammalian epidermis. J. Cell Biol. 1975; 65: 180–191
- Barry B. W. Dermatological Formulations: Percutaneous Absorption, B. W. Barry. Marcel Dekker, New York 1983; 107–116
- Surber C., Wilhelm K. P., Hori M., Maibach H. I., Guy R. H. Optimization of topical therapy: partitioning of drugs into stratum corneum. Pharm. Res. 1990; 7(12)1320–1324